Share Lupin has elevated Divya Sharma to the position of Vice President, recognizing her leadership and significant contributions to the company’s continued growth and transformation in the pharmaceutical sector. In her new role, Sharma will take on expanded responsibilities focused on driving strategic business initiatives, strengthening commercial operations, and supporting Lupin’s long-term growth objectives. Her elevation reflects the company’s commitment to developing internal talent and building a strong leadership pipeline. With more than two decades of experience in the pharmaceutical and healthcare industry, Sharma has built expertise across commercial strategy, marketing, business development, and organizational leadership. Prior to joining Lupin, she held leadership roles at Cipla, Abbott, and Ranbaxy, where she successfully led growth initiatives, brand strategy, and market expansion across multiple therapeutic segments. Throughout her career, Sharma has been recognized for her ability to lead high-performing teams, deliver sustainable business growth, and drive customer-focused strategies in a highly competitive healthcare environment. Her diverse experience across leading pharmaceutical companies positions her well to contribute to Lupin’s next phase of innovation and business expansion. Divya Sharma’s elevation underscores Lupin’s continued focus on empowering internal leaders and strengthening its leadership bench. As the pharmaceutical industry continues to evolve through innovation, digital transformation, and changing patient needs, experienced leaders like Sharma will play a key role in shaping the company’s future growth and market leadership. Post navigation Volvo Cars Appoints Abhai Kumar Srivastava as India Head – Platforms Keventers Appoints Lalit Saini as Chief Business Officer
